Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Mesenchymal Stem / Stromal Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • cGMP CliniControl™ Products
      • Human Mesenchymal Stem / Stromal Cells (hMSCs)
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Cold Atmospheric Plasma Selectively Disrupts Breast Cancer Growth in a Bioprinted 3D Tumor Microenvironment Model

December 2024 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Drug Screening, Orthopedic, Tissue Engineering

Lab-grown, 3D Extracellular Matrix Particles Improve Cardiac Function and Morphology in Myocardial Ischemia

December 2024 Bioprinting, Bioprocessing, Cardiovascular, Cell Therapy, Exosomes / Extracellular Vesicles, Immunomodulation, Tissue Engineering

Good Manufacturing Practice-grade fibronectin for hollow-fiber bioreactor cell manufacture: a mesenchymal stromal cell case study

December 2024 Bioprinting, Bioprocessing, Blood, Cell Therapy, Clinical, Gene Editing, Tissue Engineering

Decellularized Extracellular Matrix Improves Mesenchymal Stromal Cell Spheroid Response to Chondrogenic Stimuli

November 2024 Bioprinting, Bioprocessing, Cardiovascular, Exosomes / Extracellular Vesicles, Orthopedic, Tissue Engineering

Validation of an automated quality control method to test sterility of two advanced therapy medicinal products: Mesenchymal stromal cells and their extracellular vesicles

November 2024 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Immunomodulation, Tissue Engineering

Culture Expansion Alters Human Bone Marrow-Derived Mesenchymal Stem Cell Production of Osteoarthritis-Relevant Cytokines and Growth Factors

November 2024 Bioprocessing, Immunomodulation, Orthopedic

The VEGF‐Mediated Cytoprotective Ability of MIF‐Licensed Mesenchymal Stromal Cells in House Dust Mite‐Induced Epithelial Damage

November 2024 Bioprocessing, Cardiovascular, Cell Therapy, Dermal and Wound, Drug Screening, Exosomes / Extracellular Vesicles, Immunomodulation, Lung, Orthopedic

The proteomic landscape of extracellular vesicles derived from human intervertebral disc cells

November 2024 Bioprinting, Bioprocessing, Cell Therapy, Exosomes / Extracellular Vesicles, Pain, Tissue Engineering

Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells

October 2024 Bioprocessing, Cell Therapy, Immunomodulation

A Bioactive Hydrogel Based on Notochordal Cell-Derived Matrix Stimulates Nucleus Pulposus Regeneration

October 2024 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Dermal and Wound, Exosomes / Extracellular Vesicles, MedTech, Devices, & Materials, Pain, Tissue Engineering
1 2 3 4 5 6 … 20 21 22 23 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Mesenchymal Stem / Stromal Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2025 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email